Cibc Private Wealth Group, LLC Elevation Oncology, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 160,530 shares of ELEV stock, worth $51,369. This represents 0.0% of its overall portfolio holdings.
Number of Shares
160,530Holding current value
$51,369% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ELEV
# of Institutions
74Shares Held
33.2MCall Options Held
65KPut Options Held
4K-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.99MShares$1.92 Million0.1% of portfolio
-
Bml Capital Management, LLC Zionsville, IN5.89MShares$1.89 Million1.24% of portfolio
-
Tang Capital Management LLC San Diego, CA4.76MShares$1.52 Million0.08% of portfolio
-
Aisling Capital Management LP New York, NY2.83MShares$907,1710.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.59MShares$827,2700.0% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $7.46M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...